CSL Limited researches, develops, manufactures, markets and distributes biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong and internationally. CSL Behring sells plasma products, gene therapies and recombinants; CSL Seqirus supplies influenza products and pandemic services to governments; and CSL Vifor offers iron deficiency and nephrology products.